Group activity
New updates
We are the only peer-reviewed journal that has been publishing open access papers on cancer immunology and immunotherapy since 2001. Come celebrate Open Access Week!
Mujtaba M Badr likes this.
Follow Cancer Immunity on Twitter for up-to-date news in #cancer immunology, @CancerImmunity
Khezar Hayat likes this.
Want to be up-to-date on #cancer #immunology news and meetings? Subscribe or follow the #openaccess journal Cancer Immunity on Twitter.
Read our collected papers on the NY-ESO-1 #antigen at Cancer Immunity: http://archive.cancerimmunity.org/collectedpapers/NY-ESO-1.htm
As an #openaccess journal, we believe that authors should retain their rights and control how they want their research disseminated over the web. #Cancer Immunity provides its content, at no cost to authors and readers, on the principle that making cancer #immunology #research freely available to the public supports a greater global exchange of knowledge.
Learn. Observe. Discover. Share. By publishing your paper with Cancer Immunity, dissemination of cancer immunology research is accelerated. www.cancerimmunity.org
We are looking for guest bloggers to provide short commentaries on current news in the field of cancer immunology and immunotherapy. If you are interested in being a guest editor for Cancer Immunity, please e-mail the editorial office: cancerimmunity@cancerimmunity.org.
Cancer Immunity, an open access journal of the Cancer Research Institute, has relaunched http://p0.vresp.com/qAXhUn
Neda Assar likes this.
Hi everyone, I'm the owner of the group Tumor Immunobiology and Metastasis. A few of us in the group are starting up a paper discussion group to talk about ground breaking articles in the field as well as other influential papers about the future of research. We're hoping to read and discuss two papers a week (one about tumor immunobiology and metastasis and another about science and research in general). If you're interested in participating and taking part in this group send me a message and we'll talk about it. Have a great weekend! ~ Chris
Cancer Research Institute and Stand Up To Cancer Announce $6 Million Dream Team Grant.
The Cancer Research Institute (CRI) and Stand Up To Cancer (SU2C), in partnership with the American Association for Cancer Research (AACR), have issued a call for letters of intent from scientists and clinical investigators interested in forming the SU2C-CRI Cancer Immunology Translational Research Dream Team.
See press release here: http://cancerresearch.org/pressroom/2012/03/07/stand-up-to-cancer-immunology-dream-team-grant/
The Cancer Research Institute (CRI) and Stand Up To Cancer (SU2C), in partnership with the American Association for Cancer Research (AACR), have issued a call for letters of intent from scientists and clinical investigators interested in forming the SU2C-CRI Cancer Immunology Translational Research Dream Team.
See press release here: http://cancerresearch.org/pressroom/2012/03/07/stand-up-to-cancer-immunology-dream-team-grant/
We are pleased to announce our plans for the relaunch of Cancer Immunity, the online, open-access journal of the Cancer Research Institute. Over the coming months, we will be substantially modernizing the journal, including a new look, a redesigned website, and a streamlined journal management system, and will be expanding the journal’s Editorial Board to represent more broadly CRI’s many programs and constituencies.
In parallel, we are preparing a special relaunch issue dedicated to Dr. Lloyd Old, who founded Cancer Immunity in 2001, which is scheduled for publication on May 1, 2012. The issue will feature a collection of personal reflections by some of Dr. Old’s closest collaborators, reflecting on Dr. Old and his work at different points throughout his career. Also included in the issue will be a set of scientific commentaries on the topic of antibodies in cancer treatment.
For more information about the relaunch issue, please see the announcement at http://bit.ly/CIrelaunch.
In parallel, we are preparing a special relaunch issue dedicated to Dr. Lloyd Old, who founded Cancer Immunity in 2001, which is scheduled for publication on May 1, 2012. The issue will feature a collection of personal reflections by some of Dr. Old’s closest collaborators, reflecting on Dr. Old and his work at different points throughout his career. Also included in the issue will be a set of scientific commentaries on the topic of antibodies in cancer treatment.
For more information about the relaunch issue, please see the announcement at http://bit.ly/CIrelaunch.
Mahboob Imtiyaz and Dainius Characiejus like this.
Now the official Journal of the Cancer Research Institute, Cancer Immunity is making strides to a May 2012 relaunch. Stay tuned!
I would want to know if anyone could be having an idea of how Multi-plex flow cytomery could be used to assess antibody-antigen interactions during therapy in cancer progress. Kindly assist with the information and if possible some publications.
Cancer Immunity has dedicated an online memorial to our founding editor-in-chief, Dr. Lloyd Old, the "Father of Modern Tumor Immunology." Please visit http://www.cancerimmunity.org/LJO/tribute.html and see our collection of tributes, publications, and other resources that highlight his significant contributions to the field of cancer immunology and immunotherapy. If you would like to sign our guestbook, please e-mail cancerimmunity@cancerimmunity.org.
Great link. Thanks for sharing!
Volker Huppert @Mahboob
12th January
Mahboob Imtiyaz My pleasure...
14th January
chen jing Nice to you
15th January
About this group
Cancer Immunity (ISSN 1424-9634) is an open access, peer reviewed journal of the Cancer Research Institute that publishes laboratory and clinical research papers focusing on the immune response to cancer. Visit http://www.cancerimmunity.org for more information, or to publish with us.
Sign up today - FREE
Mendeley saves you time finding and organizing research. Learn more
- All your research in one place
- Add and import papers easily
- Access it anywhere, anytime
Best,
Neda